AEX-24

N/A

Report date: 2024/07/01 17:39:57

Base Information

Drug NameAEX-24
Drug Alias NameAEX-24
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 2 agonistsSomatostatin receptor 1 agonists
TargetsOrexin receptor type 2Somatostatin receptor 1
Therapy Area/IndicationsParkinson DiseaseCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAexon Labs Inc
China Registration ClassN/A

Develop Information

Active CompaniesAexon Labs IncNLS Pharmaceutics Ltd
Inactive CompaniesN/A
Active IndicationsParkinson DiseaseCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A